These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31907996)

  • 1. Mdm2 is a target and mediator of IRP2 in cell growth control.
    Zhang J; Kong X; Zhang Y; Sun W; Xu E; Chen X
    FASEB J; 2020 Feb; 34(2):2301-2311. PubMed ID: 31907996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron Regulatory Protein 2 Exerts its Oncogenic Activities by Suppressing TAp63 Expression.
    Zhang Y; Feng X; Zhang J; Chen X
    Mol Cancer Res; 2020 Jul; 18(7):1039-1049. PubMed ID: 32276991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDXR regulates TP73 tumor suppressor via IRP2 to modulate aging and tumor suppression.
    Zhang J; Kong X; Zhang Y; Sun W; Wang J; Chen M; Chen X
    J Pathol; 2020 Jul; 251(3):284-296. PubMed ID: 32304229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple, conserved iron-responsive elements in the 3'-untranslated region of transferrin receptor mRNA enhance binding of iron regulatory protein 2.
    Erlitzki R; Long JC; Theil EC
    J Biol Chem; 2002 Nov; 277(45):42579-87. PubMed ID: 12200453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mice Deficient in the RNA-Binding Protein Zfp871 Are Prone to Early Death and Steatohepatitis in Part through the p53-Mdm2 Axis.
    Mohibi S; Zhang J; Chen M; Chen X
    Mol Cancer Res; 2021 Oct; 19(10):1751-1762. PubMed ID: 34257081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 expression is repressed by the RNA-binding protein RNPC1 via mRNA stability.
    Xu E; Zhang J; Chen X
    Oncogene; 2013 Apr; 32(17):2169-78. PubMed ID: 22710720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferredoxin reductase is critical for p53-dependent tumor suppression via iron regulatory protein 2.
    Zhang Y; Qian Y; Zhang J; Yan W; Jung YS; Chen M; Huang E; Lloyd K; Duan Y; Wang J; Liu G; Chen X
    Genes Dev; 2017 Jun; 31(12):1243-1256. PubMed ID: 28747430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tempol-mediated activation of latent iron regulatory protein activity prevents symptoms of neurodegenerative disease in IRP2 knockout mice.
    Ghosh MC; Tong WH; Zhang D; Ollivierre-Wilson H; Singh A; Krishna MC; Mitchell JB; Rouault TA
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):12028-33. PubMed ID: 18685102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diurnal control of iron responsive element containing mRNAs through iron regulatory proteins IRP1 and IRP2 is mediated by feeding rhythms.
    Nadimpalli HP; Katsioudi G; Arpa ES; Chikhaoui L; Arpat AB; Liechti A; Palais G; Tessmer C; Hofmann I; Galy B; Gatfield D
    Genome Biol; 2024 May; 25(1):128. PubMed ID: 38773499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The involvement of IRP2-induced ferroptosis through the p53-SLC7A11-ALOX12 pathway in Parkinson's disease.
    Yao Z; Jia F; Wang S; Jiao Q; Du X; Chen X; Jiang H
    Free Radic Biol Med; 2024 Sep; 222():386-396. PubMed ID: 38936518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron-independent phosphorylation of iron regulatory protein 2 regulates ferritin during the cell cycle.
    Wallander ML; Zumbrennen KB; Rodansky ES; Romney SJ; Leibold EA
    J Biol Chem; 2008 Aug; 283(35):23589-98. PubMed ID: 18574241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron overload induced by IRP2 gene knockout aggravates symptoms of Parkinson's disease.
    Ci YZ; Li H; You LH; Jin Y; Zhou R; Gao G; Hoi MPM; Wang C; Chang YZ; Yu P
    Neurochem Int; 2020 Mar; 134():104657. PubMed ID: 31904393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox control of iron regulatory protein 2 stability.
    Hausmann A; Lee J; Pantopoulos K
    FEBS Lett; 2011 Feb; 585(4):687-92. PubMed ID: 21281640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excess capacity of the iron regulatory protein system.
    Wang W; Di X; D'Agostino RB; Torti SV; Torti FM
    J Biol Chem; 2007 Aug; 282(34):24650-9. PubMed ID: 17604281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron regulatory protein-1 and -2: transcriptome-wide definition of binding mRNAs and shaping of the cellular proteome by iron regulatory proteins.
    Sanchez M; Galy B; Schwanhaeusser B; Blake J; Bähr-Ivacevic T; Benes V; Selbach M; Muckenthaler MU; Hentze MW
    Blood; 2011 Nov; 118(22):e168-79. PubMed ID: 21940823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for lysosomes in the turnover of human iron regulatory protein 2.
    Dycke C; Charbonnier P; Pantopoulos K; Moulis JM
    Int J Biochem Cell Biol; 2008; 40(12):2826-32. PubMed ID: 18582596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p73 expression is regulated by ribosomal protein RPL26 through mRNA translation and protein stability.
    Zhang M; Zhang J; Yan W; Chen X
    Oncotarget; 2016 Nov; 7(48):78255-78268. PubMed ID: 27825141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron regulatory protein 2 is a suppressor of mutant p53 in tumorigenesis.
    Zhang Y; Feng X; Zhang J; Chen M; Huang E; Chen X
    Oncogene; 2019 Aug; 38(35):6256-6269. PubMed ID: 31332290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron regulatory protein 2 turnover through a nonproteasomal pathway.
    Chang AH; Jeong J; Levine RL
    J Biol Chem; 2011 Jul; 286(27):23698-707. PubMed ID: 21558272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
    Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.